Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which engages in the manufacture, development and market of products and tools for clinical research, translational research, drug development and bioscience research. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in August 1976 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
136
Frequently Asked Questions
What is Market Cap of Enzo Biochem, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Enzo Biochem, Inc. market cap is $36.59M.
What is the 52-week high for Enzo Biochem, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Enzo Biochem, Inc. 52 week high is $1.19 as of September 14, 2025.
What is the 52-week low for Enzo Biochem, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Enzo Biochem, Inc. 52 week low is $0.252 as of September 14, 2025.
What is Enzo Biochem, Inc. stock price today?
Enzo Biochem, Inc. stock price today is $0.6989.
What was Enzo Biochem, Inc. stock price yesterday?
Enzo Biochem, Inc. stock price yesterday was $0.6875.
What is the PE ratio of Enzo Biochem, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Enzo Biochem, Inc.’s P/E ratio is -1.73.
What is the Price-to-Book ratio of Enzo Biochem, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Enzo Biochem, Inc. P/B ratio is 0.8439.
What is the 50-day moving average of Enzo Biochem, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Enzo Biochem, Inc. 50-day moving average is $0.66.
